Overview

Semax (ACTH 4–10 analogue) for research use only, is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH). It is widely used in neuroendocrine and neuroscience research due to its involvement in neurotrophic signalling pathways and central nervous system activity models.

This vial contains 5mg of Semax, supplied lyophilised (freeze-dried), research grade, in a sealed vial. Each batch is supplied with a Certificate of Analysis confirming purity and identity testing carried out at the point of manufacture, published on this page before sale.

Semax is investigated in research settings including neuropeptide signalling, synaptic plasticity models, neurotrophic factor regulation, and neuroendocrine system research. Velyx makes no health claims about this compound.

What's included

• 1 × Semax 5mg vial — lyophilised, research grade
• Tracked UK delivery

Research use only. Not for human or veterinary consumption. By purchasing you confirm you are 18 or over and understand the research-use-only nature of this product.

Research

Fields of study

Semax appears in peer-reviewed research literature on:

• Neurotrophic signalling and BDNF regulation pathways
• Neuroprotection and oxidative stress response models
• Dopaminergic and serotonergic signalling research
• Neuroendocrine and hypothalamic–pituitary system studies
• Cognitive and synaptic plasticity research models

Related research — selected papers

• Levitskaya NG, Sebentsova EA, Andreeva LA, Alfeeva LYu, Kamenskii AA, Myasoedov NF. The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system. Neuroscience and Behavioral Physiology. 2004.
• Ashmarin IP, Nezavibat'ko VN, Myasoedov NF, et al. A nootropic analog of adrenocorticotrophic hormone 4–10 — Semax. Zh Vyssh Nerv Deyat Im I P Pavlova. 1997;47(2):420–430.
• Bashkatova VG, Koshelev VB, Fadyukova OE, et al. Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia. 2001.

Velyx publishes peer-reviewed research citations for context only. No therapeutic claim is made or implied.

Certificates of Analysis

This vial of Semax 5mg is supplied with access to its batch-specific Certificate of Analysis using validated chromatographic and spectrometric techniques. The COA displayed below corresponds to the exact batch you receive.

• Semax 5mg — Batch 26098 — Download COA PDF

Each batch is supplied with documentation from our manufacturing partner covering HPLC purity, identity verification, endotoxin (LAL assay), heavy metals (Class 1 and 2), and bioburden (TAMC and TYMC) testing. Independent third-party verification is the next stage of our quality programme.

COA will be published here before this batch ships.

Preparation & Storage

Reconstitution

This vial arrives lyophilised (freeze-dried powder) and requires reconstitution with bacteriostatic water before use in research.

Storage

• Before reconstitution (lyophilised): refrigerate at 2–8°C. Avoid light. Do not freeze.
• After reconstitution: refrigerate at 2–8°C. Use within 14–30 days.
• In transit: shipped with insulated packaging.

Bacteriostatic water is not included. Available as a Velyx add-on.

All products sold by Velyx Research Ltd are for research purposes only and are not intended for human consumption. By purchasing from this site you confirm that you are 18 or over and understand the research-use-only nature of all products.

Reviews

Verified customer reviews will appear here as orders ship and reviews are submitted. All reviews are post-purchase and unincentivised.